ILLUMINA INC (ILMN) Stock Price, Forecast & Analysis
NASDAQ:ILMN • US4523271090
ILMN Key Statistics, Chart & Performance
The current stock price of ILMN is 122.9 USD. In the past month the price decreased by -19.67%. In the past year, price increased by 38.49%.
ILMN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ILMN. When comparing the yearly performance of all stocks, ILMN is one of the better performing stocks in the market, outperforming 74.33% of all stocks.
ILMN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ILMN. ILMN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
ILMN Financial Highlights
Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 4.85. The EPS increased by 97.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.57% | ||
| ROA | 12.79% | ||
| ROE | 31.22% | ||
| Debt/Equity | 0.55 |
ILMN Forecast & Estimates
26 analysts have analysed ILMN and the average price target is 135.91 USD. This implies a price increase of 10.59% is expected in the next year compared to the current price of 122.9.
For the next year, analysts expect an EPS growth of 6.75% and a revenue growth 5.78% for ILMN
ILMN Ownership
ILMN Latest News, Press Relases and Analysis
ILMN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.77 | 193.716B | ||
| DHR | DANAHER CORP | 24.63 | 147.876B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 142.41 | 47.316B | ||
| A | AGILENT TECHNOLOGIES INC | 20.55 | 35.185B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.84 | 28.049B | ||
| IQV | IQVIA HOLDINGS INC | 12.6 | 27.964B | ||
| WAT | WATERS CORP | 22.55 | 19.425B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.26 | 17.653B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.31 | 12.457B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ILMN
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 9000
Phone: 18582024500
ILLUMINA INC / ILMN FAQ
Can you describe the business of ILLUMINA INC?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Can you provide the latest stock price for ILLUMINA INC?
The current stock price of ILMN is 122.9 USD. The price increased by 1.96% in the last trading session.
Does ILLUMINA INC pay dividends?
ILMN does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILMN stock?
ILMN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about ILLUMINA INC (ILMN) stock?
26 analysts have analysed ILMN and the average price target is 135.91 USD. This implies a price increase of 10.59% is expected in the next year compared to the current price of 122.9.
What sector and industry does ILLUMINA INC belong to?
ILLUMINA INC (ILMN) operates in the Health Care sector and the Life Sciences Tools & Services industry.